瘤疗法的眼部副作用:审查
M Asencio-Durán1, E Fernández-Gutiérrez1, M Larrañaga-Cores1
1Servicio de Oftalmología, Hospital Universitario La Paz, Instituto de Investigación Sanitaria del Hospital La Paz (IDIPAZ), Madrid, Spain.
Archivos de la Sociedad Espanola de Oftalmologia
|November 10, 2023
概括
最近的癌症疗法改善了患者的生存率,但引入了新的不良影响. 眼科医生必须识别和管理与先进的癌症治疗相关的这些新的眼部并发症.
科学领域:
- 在瘤学瘤学.
- 眼科医生 眼科 眼科
背景情况:
- 癌症治疗的进步显著改善了以前无法治愈的瘤患者的生存率和生活质量.
- 新的癌症药物虽然比传统化疗毒性更小,但具有独特的副作用.
- 眼科医生在识别和管理这些与治疗相关的眼部并发症方面发挥着至关重要的作用.
研究的目的:
- 为了突出眼科中由于先进的癌症疗法而出现的新不良影响.
- 强调眼科医生需要意识到并管理这些特定的眼部并发症.
主要方法:
- 审查癌症治疗的最新进展.
- 在临床实践和文献中报告的相关眼部不良影响的分析.
主要成果:
- 癌症患者的生存率增加.
- 鉴定了一系列与新型癌症疗法相关的新型眼部不良影响.
- 需要专门的眼科知识来管理这些影响.
结论:
- 现代癌症治疗改善了患者的结果,但需要警的眼科监测.
- 眼科医生必须准备好诊断和治疗由创新的癌症疗法引起的新的眼睛毒性.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Glaucoma: Overview
595
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
595
Open Angle Glaucoma: Treatment
459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
459
Angle Closure Glaucoma: Treatment
534
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
534
Accessory Structures of the Eye
1.6K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


